openPR Logo
Press release

L-Hydroxyphenylalanine Market Expected to Behold a CAGR of 3.5% through 2018 to 2028

07-26-2018 05:12 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

L-Hydroxyphenylalanine Market Expected to Behold a CAGR of 3.5%

As a part of the amino acid family, use of L-hydroxyphenylalanine as an energy providing aromatic ingredient has significantly fuelled its demand across the dietary supplement and nutraceuticals space. This factor continues to remain instrumental in driving the growth of the L-hydroxyphenylalanine market during the period of forecast. Moreover, various pharmaceutical uses of L-hydroxyphenylalanine including its application in formulations to treat Parkinson’s disease, Alzheimer’s disease and cancer are also expected to contribute to the overall growth of the L-hydroxyphenylalanine market. Being recognized as GRAS (Generally Recognized as Safe) by the FDA, the use of L-hydroxyphenylalanine in food and beverage sector has also witnessed significant growth in recent times.

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=918

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.
Request Report Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=918

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-hydroxyphenylalanine market, as studies reveal the potential of the L-hydroxyphenylalanine in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-hydroxyphenylalanine as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-hydroxyphenylalanine, consequently fuelling the growth of the L-hydroxyphenylalanine market during the forecast period.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release L-Hydroxyphenylalanine Market Expected to Behold a CAGR of 3.5% through 2018 to 2028 here

News-ID: 1148488 • Views:

More Releases from Fact.MR

Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 2033
Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 203 …
It is Anticipated That the Toy Drone Market Will Reach US$ 951.5 Million by 2033 At A CAGR of 8.6% | Fact.MR growing Children's Propensity for Playing with Drones for Recreation Will Support Market Expansion the global toy drone market is anticipated to reach US$ 417 million in 2023 and develop at a compound annual growth rate (CAGR) of 8.6% over the forecast period of 2023-2033, according to Fact.MR. Because
Waterjet Cutting Machine Market Overview: Reaching US$ 74.01 Billion by 2034
Waterjet Cutting Machine Market Overview: Reaching US$ 74.01 Billion by 2034
By the end of 2033, the Waterjet Cutting Machines Market is anticipated to be worth US $1.88 billion, with a compound annual growth rate (CAGR) of 4.8%. with a compound annual growth rate (CAGR) of 5.4%, the market for waterjet 3D cutting machines is projected to reach US$ 895.9 million. The German market is predicted to earn US$ 92.22 million in sales by the end of 2033, expanding at a
Smart E-Drive Market Projected to Hit $12 Billion by 2033 with 29.5% CAGR Growth
Smart E-Drive Market Projected to Hit $12 Billion by 2033 with 29.5% CAGR Growth
The global smart e-drive market (Mercado de e-Drive inteligente) is expected to reach $12 billion by 2033, growing at a 29.5% CAGR between 2023 and 2033. Smart e-drive is an improved form of an electric drive system that has been modified to make driving more comfortable and safer. In this example, the power source is a battery, which could be lead-based, lithium-ion, or solid-state; this battery allows energy to be transmitted
Global Form Fill and Sealing Equipment Market Projected to Reach $17.3 Billion by 2032
Global Form Fill and Sealing Equipment Market Projected to Reach $17.3 Billion b …
The global form fill and sealing (FFS) equipment market (Markt für Formfüll- und Verschließgeräte (FFS)) is valued at $9.3 billion in 2022 and is expected to grow to $17.3 billion by 2032. FFS equipment is a fully automatic machine that is used to boost the efficiency and accuracy of packaging and is one of the best options for packing various goods, such as liquid-filled bottles, containers, and powdered food products. A

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutics Market 2021 | Detailed Report
Global Parkinson’s Disease Therapeutics Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,